Center for Personalized Cancer Treatment

Institution (Healthcare)

Homepage ROR

Also Known As

Center for Personalized Cancer Treatment · Acronym: CPCT

364

Publications

69.3K

Citations

Authors

162

Concepts

About

Center for Personalized Cancer Treatment is a healthcare institution in Rotterdam, Netherlands known for medicine, cancer research, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	30	168	12.5K
2	Engineering	10	29	3.1K
3	Health Sciences	10	40	2.1K
4	Education	1	2	34
5	Natural Sciences	1	2	46

Center for Personalized Cancer Treatment

364

Publications

69.3K

Citations

Page 1

	Year	Citations
Tumor Mutational Burden as an Independent Predictor of Response to Immunotherapy in Diverse Cancers Aaron M. Goodman, Shumei Kato, Lyudmila Bazhenova, Molecular Cancer Therapeutics	2017	2.3K
Pan-cancer whole-genome analyses of metastatic solid tumours Peter Priestley, Jonathan Baber, Martijn P. Lolkema, Nature	2019	1.1K
Mutational signature in colorectal cancer caused by genotoxic pks+ E. coli Cayetano Pleguezuelos‐Manzano, Jens Puschhof, Axel Rosendahl Huber, Nature MedicinePathogenesisColorectal CancerPathologyMolecular Pathology	2020	1.1K
Hyperprogressors after Immunotherapy: Analysis of Genomic Alterations Associated with Accelerated Growth Rate Shumei Kato, Aaron M. Goodman, Vighnesh Walavalkar, Clinical Cancer Research	2017	837
The FGFR Landscape in Cancer: Analysis of 4,853 Tumors by Next-Generation Sequencing Teresa Helsten, Sheryl K. Elkin, Elisa Arthur, Clinical Cancer Research	2015	786
Pan-cancer landscape of homologous recombination deficiency Luan Nguyen, John W.M. Martens, Arne van Hoeck, Nature Communications	2020	507
High prevalence of mutantKRAS in circulating exosome-derived DNA from early-stage pancreatic cancer patients Kelvin Allenson, J.J. Soto Castillo, F Anthony San Lucas, Annals of Oncology Pancreatic CancerMedicineExosome-derived DnaPathologyHigh Prevalence	2017	471
Pancreatic cancer organoids recapitulate disease and allow personalized drug screening Else Driehuis, Arne van Hoeck, Kat Moore, Proceedings of the National Academy of Sciences	2019	455
Ovarian Cancer Cell Line Panel (OCCP): Clinical Importance of In Vitro Morphological Subtypes Corine M. Beaufort, Jean Helmijr, Anna Piskorz, PLoS ONE Tumoral PathologyClinical ImportanceTumor HeterogeneityEpithelial Ovarian CancerMedicine	2014	404
Ph-like acute lymphoblastic leukemia: a high-risk subtype in adults Nitin Jain, Kathryn G. Roberts, Elias Jabbour, Blood	2016	376

Page 1